Your browser doesn't support javascript.
loading
Combined BET bromodomain and CDK2 inhibition in MYC-driven medulloblastoma.
Bolin, Sara; Borgenvik, Anna; Persson, Camilla U; Sundström, Anders; Qi, Jun; Bradner, James E; Weiss, William A; Cho, Yoon-Jae; Weishaupt, Holger; Swartling, Fredrik J.
Afiliação
  • Bolin S; Department of Immunology, Genetics and Pathology, Science for Life Laboratory, Rudbeck Laboratory, Uppsala University, Uppsala, Sweden.
  • Borgenvik A; Department of Immunology, Genetics and Pathology, Science for Life Laboratory, Rudbeck Laboratory, Uppsala University, Uppsala, Sweden.
  • Persson CU; Department of Immunology, Genetics and Pathology, Science for Life Laboratory, Rudbeck Laboratory, Uppsala University, Uppsala, Sweden.
  • Sundström A; Department of Immunology, Genetics and Pathology, Science for Life Laboratory, Rudbeck Laboratory, Uppsala University, Uppsala, Sweden.
  • Qi J; Department of Medicine, Harvard Medical School; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.
  • Bradner JE; Department of Medicine, Harvard Medical School; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.
  • Weiss WA; Departments of Neurology, Pediatrics and Neurosurgery, University of California, San Francisco, CA, USA.
  • Cho YJ; Department of Pediatrics, Papé Family Pediatric Research Institute, Knight Cancer Institute, Oregon Health & Science University, Portland, OR, USA.
  • Weishaupt H; Department of Immunology, Genetics and Pathology, Science for Life Laboratory, Rudbeck Laboratory, Uppsala University, Uppsala, Sweden.
  • Swartling FJ; Department of Immunology, Genetics and Pathology, Science for Life Laboratory, Rudbeck Laboratory, Uppsala University, Uppsala, Sweden. fredrik.swartling@igp.uu.se.
Oncogene ; 37(21): 2850-2862, 2018 05.
Article em En | MEDLINE | ID: mdl-29511348
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Azepinas / Triazóis / Neoplasias Cerebelares / Proteínas Proto-Oncogênicas c-myc / Inibidores de Proteínas Quinases / Meduloblastoma Limite: Female / Humans Idioma: En Ano de publicação: 2018 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Azepinas / Triazóis / Neoplasias Cerebelares / Proteínas Proto-Oncogênicas c-myc / Inibidores de Proteínas Quinases / Meduloblastoma Limite: Female / Humans Idioma: En Ano de publicação: 2018 Tipo de documento: Article